Dr Walley is Associate Professor of Medicine and an addiction expert at Boston Medical Center and Boston University School of Medicine. Dr Walley has conducted multiple studies related to the opioid crisis and the integration of addiction specialty care and general medical care. He has served as PI on a CDC-SAMHSA-Epi-AID investigation of the surge in fentanyl-related overdose, a CDC-funded study of the Massachusetts OEND program which demonstrated community-level reductions in overdose death rates, and a SAMHSA-funded program that integrated addiction treatment into the clinical care of people with/at risk for HIV. He has worked as Co-I with addiction, overdose, and HIV expertise on NIDA and NIAAA-funded clinical trials and cohort studies.
Dr Walley is the director of the Boston Medical Center Addiction Medicine Fellowship program, as well as the director the NIDA-funded Fellow Immersion Training program in Addiction Medicine, which trains 5 subspecialty fellows each year to integrate addiction science into their subspecialty research. He provides primary care and addiction medicine consultations in the HIV primary care clinic at Boston University School of Medicine/BMC where he leads the FAST PATH (Facilitated Access to Substance abuse Treatment for Prevention and Treatment of HIV) program. Dr Walley co-founded and provides care on the inpatient addiction consult service at Boston Medical Center, which regularly provides consultation for patients admitted to the hospital who use alcohol and substances. Lastly, Dr Walley has been the medical director of the Massachusetts Opioid Overdose Prevention program since it started in 2007. They have trained and equipped over 80,000 people in the community with naloxone rescue kits, culminating in over 19,000 documented overdose rescues.
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine
- Courtesy Staff Privileges, Medicine, Boston Medical Center
- Johns Hopkins University School of Medicine, MD
- Boston University School of Public Health, MSc
- Harvard College, AB
- Published on 6/1/2021
Kimmel S, Bach P, Walley AY. Treatment of Refractory Opioid Use Disorder : Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: A Narrative Review. J Gen Intern Med. 2021 Jun; 36(6):1793. PMID: 33772440.
- Published on 4/20/2021
Roy PJ, Price R, Choi S, Weinstein ZM, Bernstein E, Cunningham CO, Walley AY. Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge. Drug Alcohol Depend. 2021 Jul 01; 224:108703. PMID: 33964730.
- Published on 4/9/2021
Jawa R, Rozansky H, Clemens D, Fagan M, Walley AY. Rethinking Home-based Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Drugs: An Opportunity for Change in the Time of COVID-19. J Addict Med. 2021 Apr 09. PMID: 33870955.
- Published on 4/1/2021
Kerensky T, LaRochelle M, Fan SL, Kosakowski S, Wason K, Walley AY. Non-prescription Fentanyl Positive Toxicology: Prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use. J Addict Med. 2021 Apr 01; 15(2):150-154. PMID: 32909981.
- Published on 3/15/2021
Kimmel SD, Walley AY, Lodi S, Forman LS, Liebschutz JM, Lira MC, Kim TW, Del Rio C, Samet JH, Tsui JI. Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy. AIDS. 2021 03 15; 35(4):697-700. PMID: 33587441.
- Published on 2/1/2021
Linas BP, Savinkina A, Madushani RWMA, Wang J, Eftekhari Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Netw Open. 2021 02 01; 4(2):e2037259. PMID: 33587136.
- Published on 1/27/2021
Harris MTH, Bagley SM, Maschke A, Schoenberger SF, Sampath S, Walley AY, Gunn CM. Competing risks of women and men who use fentanyl: "The number one thing I worry about would be my safety and number two would be overdose". J Subst Abuse Treat. 2021 06; 125:108313. PMID: 34016300.
- Published on 1/1/2021
Thakarar K, Kulkarni A, Lodi S, Walley AY, Lira MC, Forman LS, Colasanti JA, Del Rio C, Samet JH. Emergency Department Utilization Among People Living With HIV on Chronic Opioid Therapy. J Int Assoc Provid AIDS Care. 2021 Jan-Dec; 20:23259582211010952. PMID: 33888001.
- Published on 1/1/2021
Kimmel SD, Rosenmoss S, Bearnot B, Larochelle M, Walley AY. Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts. J Addict Med. 2021 Jan-Feb 01; 15(1):20-26. PMID: 32675798.
- Published on 12/31/2020
Formica SW, Waye KM, Benintendi AO, Yan S, Bagley SM, Beletsky L, Carroll JJ, Xuan Z, Rosenbloom D, Apsler R, Green TC, Hunter A, Walley AY. Characteristics of post-overdose public health-public safety outreach in Massachusetts. Drug Alcohol Depend. 2021 02 01; 219:108499. PMID: 33421800.
View 144 more publications: View full profile at BUMC